MedPath

Comparison of Two Endoscopically Placed Nasojejunal Probes

Not Applicable
Conditions
Investigation Time
Registration Number
NCT02705027
Lead Sponsor
Ruhr University of Bochum
Brief Summary

A direct application of jejunal tube feeding is necessary especially in patients with gastroparesis due of existing diabetes mellitus, postoperative or severe underlying disease. Since the jejunal tube feedings, the secretion of gastric juice can be increased, the use of probes that allow both: jejunal nutrition, as well as a gastric outflow of secretions are beneficial.

While in a randomized trial of Schwab et al. it could be shown that the use of Freka-Trilumina® compared to Dobbhoff probe by so-called drag technique is significantly faster there are currently no comparative data to use the Easy-In® probe subsequently developed , which is directly introduced through the working channel of the endoscope, and thus shortening the procedure time.

Detailed Description

The use of probes nasojejunal has increasingly become important especially in critically ill patients because of the beneficial effect in patients e.g. with necrotizing pancreatitis, according trauma or major surgical procedures.

A direct application of jejunal tube feeding is necessary especially in patients with gastroparesis due of existing diabetes mellitus, postoperative or severe underlying disease. Since the jejunal tube feedings, the secretion of gastric juice can be increased, the use of probes that allow both: jejunal nutrition, as well as a gastric outflow of secretions are beneficial.

While in a randomized trial of Schwab et al. it could be shown that the use of Freka-Trilumina® compared to Dobbhoff probe by so-called drag technique is significantly faster there are currently no comparative data to use the Easy-In® probe subsequently developed , which is directly introduced through the working channel of the endoscope, and thus shortening the procedure time.

In the presented study should be investigated to what extent the use of imported directly via the working channel Easy-Inn® probe, application time and thus the investigation period may be shortened compared to the usual nasojenunal probes.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
64
Inclusion Criteria
  • Age ≥ 18 years
  • Clinical indication for enteral feeding via naso-jejunal probe
Exclusion Criteria
  • Lack of consent of the patient or their relatives (in intubated and mechanically ventilated patients in intensive care)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Examination time for the probe systemThrough study completion, an average of 1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

PD Dr. Andrea Riphaus

🇩🇪

Hannover, Germany

Klinikum Agness Karll Laatzen

🇩🇪

Laatzen, Germany

PD Dr. Andrea Riphaus
🇩🇪Hannover, Germany
Andrea Riphaus, MD, PhD
Contact
0049-511-8208
ariphaus@web.de

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.